Denmark's Lundbeck has said that efforts to build its R&D portfolio are on track to deliver four new molecular entities (NMEs ...

Pharmaceuticals and Sobi announced that results from the Phase 3 VALIANT study were presented as an oral presentation during the High-Impact Clinical Trials session at the American Society of ...

Crypto.com Arena, which celebrated its 25th anniversary this month, has completed phase three of its nine-figure, ...

Bitcoin’s (BTC) price has climbed 55% so far in 2024, including 12.50% gains in October. Its recent increases have been ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on ...

Enterprises are poised to take artificial intelligence to the next level, building on initial forays into AI that mostly ...

Wuthering Waves version 1.3 phase II is out now It brings a plethora of in-game events Version 1.3 previously introduced a ...

BriaCell Therapeutics could access a $1-$5 billion market upon approval despite a sub-$30 million cap. See more on BRIA stock ...

Project on offer comprises the first phase of Aramco’s accelerated carbon capture and storage (ACCS) development, which is ...

The UK’s competition regulator is investigating whether Alphabet’s $2.3 billion investment in AI startup Anthropic harms UK ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that initial safety and ...

The Eagles' young DBs will certainly be tested Sunday against the Cincinnati Bengals behind quarterback Joe Burrow and his ...